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Periprosthetic joint infections are devastating complications for patients and for our health system. With growing demand for
arthroplasty, the incidence of these infections is projected to increase exponentially.This paper is a review of existing animalmodels
to study periprosthetic infection aimed at providing scientists with a succinct presentation of strengths and weaknesses of available
in vivo systems. These systems represent the tools available to investigate novel antimicrobial therapies and reduce the clinical and
economic impact of implant infections.
1. Introduction
Periprosthetic joint infection is a devastating complication
of total joint arthroplasty. Despite advances in perioperative
antibiotics and aseptic surgical technique, periprosthetic
joint infection is currently the most common indication for
revision total knee arthroplasty and the third most common
indication for revision total hip arthroplasty in the United
States [1]. Postarthroplasty infections occur in approximately
1% of primary arthroplasties and 3%–5% of revisions [2–
6] and the incidence of infections continues to rise with
the increasing demand for arthroplasty surgery. The annual
number of total knee arthroplasties performed in the United
States is estimated to reach 3.48 million by 2030, while the
number of total hip arthroplasties is projected to increase to
572,000. With this projection of roughly 4 million arthro-
plasty surgeries performed each year by 2030, the annual
incidence of arthroplasty infection is projected to rise from its
2005 estimate of 17,000 to a projected 266,000 by 2030 [3, 7, 8].
Arthroplasty infections are clinically devastating, often
leading to multiple operations, prolonged hospitalization,
and worse clinical outcomes. Severe infections often lead
to amputation and can even result in death [9, 10]. These
infections also pose a significant economic burden through
direct medical costs and lost wages and productivity [7].
Medical costs alone average $144,514 per patient (compared
with $30,173 for an uncomplicated arthroplasty) [9], which
corresponds to a projected annual national healthcare burden
of $8.63 billion by 2015 [8].
When arthroplasty implants become infected, they are
exceedingly difficult to treat, especially when such an infec-
tion presents in a chronic setting. The bacteria produce a
biofilm, a polysaccharide layer that blocks the penetration
of antibiotics and cells of the host immune system [2, 11,
12]. The majority of such infections, approximately 70%,
are caused by staphylococcal species. Over the past decade,
hospitals have seen an increase in arthroplasty infection by
antibiotic-resistant strains, themost common beingmethicil-
lin-resistant Staphylococcus aureus [13–15].
Two fundamental criteria are used to classify peripros-
thetic joint infections:mechanism of infection and the timing
of diagnosis. Themechanism of infection can be either direct
seeding of the implant at the time of surgery or hematogenous
spread of infection from elsewhere in the body. Surgeons
attempt to prevent direct inoculation through sterile tech-
nique, perioperative antibiotics, and limiting duration of the
operation. Once an implant is in place, there is concern for
hematogenous spread any time the patient has an infection or
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transient bacteremia. Hematogenous spread of bacteria can
be minimized by aggressively treating infections elsewhere
in the body as well as prescribing prophylactic antibiotics for
small procedures that lead to postoperative bacteremia (i.e.,
dental procedures).
In terms of timing, infections that are identified in the first
4weeks after surgery orwithin 4weeks of another identifiable
source of seeding (i.e., dental work or another surgical proce-
dure) are categorized as “acute” infections. Infections greater
than 4 weeks after index surgery and with no identifiable
precipitating event are classified as “chronic” infections. This
distinction is admittedly opaque but is based on our concept
of a biofilm “establishing itself ” on the implant over some
period of time after seeding.
Current treatment protocols are driven by this timing-
based classification. Acute infections are most often
treated with irrigation and debridement, polyethylene liner
exchange, and retention of themetallic components. Concep-
tually (although with little scientific validation), acute infec-
tions can be treated with irrigation and debridement because
a mature biofilm has not yet been established. Good results
have been reported with this technique [16]. Despite
prompt management, irrigation and debridement of acute
arthroplasty infections can result in recurrent infection [17].
In one study of acutely infected total knee arthroplasties
treated with debridement, component retention, and
intravenous antibiotics, only 35% of patients successfully
retained their components at a four-year follow-up period.
When a subset analysis was performed, only 8% of patients
who were infected with S. aureus in comparison to 56%
with S. epidermidis or streptococcal species were successfully
treated via this method [18]. In addition to the virulence of
the bacteria, other important prognostic factors also need to
be considered prior to attempting component retention, such
as the immune status and past medical history of the patient.
The current standard of care for treatment of chronic
infections involves a multiple stage process beginning with
surgical removal of all prosthetic components, debridement
of the surrounding tissue, and placement of an antibiotic
impregnated cement spacer. Patients are then placed on a 6-
week course of intravenous antibiotics tailored to susceptibil-
ities of the bacteria cultured from the surgery.Once this infec-
tion clears (as supported by a benign appearing wound, nor-
mal C-reactive protein, normal erythrocyte sedimentation
rate, and negative joint aspiration cultures), a second-stage
revision arthroplasty may be attempted [3]. In a prospective
series, Mortazavi et al. reported that at an average of 3.4-
year follow-up, 28% of patients who had a two-stage revision
arthroplasty for an infected total knee arthroplasty required
reoperation for infection [19]. In severe or persistent infec-
tions, long-term suppressive antibiotic therapy, arthrodesis,
or even amputation is sometimes necessary [20, 21].
2. A History of Animal Models
There are a lot of interest and research on the prevention
and treatment of implant infections since it is the single most
common cause of arthroplasty failure. As in many areas of
medicine, animal models have been used to better under-
stand the pathophysiology of post-arthroplasty infection.
Animal models are also an essential intermediary between in
vitro laboratory work and clinical trials.
The first joint infection animal model was established in
rabbits and was published in the Journal of Bone and Joint
Surgery in 1975 [22]. In this model, infection was tested in
both a native knee and a knee with metal “implants” present.
The “implant” arm of the study wasmade up ofmice who had
sterile stainless steel particles (<3𝜇m in diameter) suspended
in normal saline injected into the knee via the suprapatellar
pouch. Infection was then produced via the inoculation of
serial tenfold dilutions of a culture of either Staphylococcus
aureus or Micrococcus species into the suprapatellar pouch.
On postprocedure day 6 and at weekly intervals thereafter,
cultures of the joint fluid were obtained via placement of a
needle into the suprapatellar pouch, irrigation of the joint
with 1.5mL sterile saline, followed by aspiration and culture
of the aspirate. In this study, stainless steel particles in the
knee did not appear to increase susceptibility to infection
from injected micrococci but did make established micro-
coccal infections more persistent [22]. However, because the
metal was suspended in normal saline rather than implanted
into the bone, there was question as to how appropriately this
modeled the arthroplasty situation from both a bone-implant
interface perspective as well as an opportunity for bacterial
adherence.
The first caninemodel was described by Petty et al. in 1985
[23]. Using a sterile technique, an incision was made over
the tip of the greater trochanter and the bone was exposed
subperiosteally. A hand drill and bone awl were used to
penetrate the cortex and a 5mmdrill bit was used to ream the
medullary cavity of the femur.The canal was then inoculated
with the desired bacterial suspension (Staphylococcus epider-
midis, Staphylococcus aureus, or Escherichia coli) and a 4 by
6 cm cylinder was introduced into the canal (stainless steel
alloy, cobalt-chromium alloy, high-density polyethylene, or
polymethylmethacrylate). The wound was then closed using
a Dexon suture. At postoperative day 15, all the animals were
euthanized and tissue was retrieved and cultured. The effects
of the different implant materials on the susceptibility to
infection were then compared. This model was later used
to compare the effect of intraoperative irrigation and post-
operative antibiotic treatment on infection rate [24]. One
significant advantage of this animal model, in comparison
to the rabbit model described previously, is that the metal
implant used in this model (4 by 6 cm cylinder placed into
the proximal femur) more closely represents an arthroplasty,
in comparison to the stainless steel particles injected into the
knee joint space in the prior model. Weaknesses of the model
include the single, static data time point, postoperative day 15,
and as a questionable surgical representation. Inoculating the
bone and then placing an implant is perhaps a better model
of introducing an implant into an existing osteomyelitis. The
site of bacterial seeding is intraosseous, rather than intra-
articular.
This concern of intra-articular bacterial seeding was
addressed by a novel arthroplasty infection rabbit model
published by Craig et al. in 2005 [25]. A stainless-steel screw
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with an ultrahigh molecular weight polyethylene washer
was cemented using polymethyl methacrylate in a defect
created in an intra-articular, nonarticulating portion of the
lateral femoral condyle of each knee. This was followed by
inoculation of various concentrations of methicillin resistant
staphylococcus aureus (MRSA).The animalswere euthanized
at postoperative day 7, at which time joint aspirate, tissues,
and biomaterial samples were cultured. This model was also
used to compare the infection rate of various biomaterials
(i.e., polymethyl methacrylate (PMMA), bone cement, ultra
high molecular weight polyethylene (UHMWPE), and stain-
less steel) [25]. One advantage of this model was that bacteria
were introduced directly into the knee joint following wound
closure whereas older models inserted bacteria directly into
the femoral canal prior to implant placement or immersed
biomaterials in a bacterial suspension prior to intra-articular
placement.Thismethod of inoculationmore closelymodeled
an arthroplasty infection. A second advantage of this model
was that it included the major biomaterials used in total knee
arthroplasty, with use of PMMA, UHMWPE, and metal.
Anothermodification addressed by recentwork in animal
modeling has been based on the observation that a significant
number of hardware infections may be the result of inocu-
lation by mature bacterial biofilms rather than independent
bacteria [26–32]. Williams et al. explored this observation
and hypothesize that using a biofilm as initial inocula, rather
than native bacteria, may provide more clinically relevant
information for the prevention and treatment of hardware
infections. In this model, a clinical isolate of methicillin-
resistant S. aureus was used and was grown on the surface
of membranes composed of polyetheretherketone (PEEK)
for 48 hours. The biofilms were then isolated and used
as an inoculum in a Gustilo type IIIB open tibia fracture
model in sheep. An anterior midline sagittal incision was
made from the tibial tuberosity extending distally along the
anterior aspect of the tibia. In order to mimic a type IIIB
Gustilo open fracture with significant periosteal stripping,
bone exposure, and massive contamination, a section of
periosteum was removed from the proximal anteromedial
aspect of the tibia. A construct consisting of a stainless steel
plate with a membrane containing the biofilm was placed
against the tibial surface with the biofilmmembrane between
the plate and cortical bone. Each plate was then secured
with cortical bone screws and the incision was finally closed
with suture (Figures 1 and 2). Postoperatively, the wound was
observed for signs of infection such as erythema, warmth,
and dehiscence. At 12 weeks postoperatively, the sheep were
euthanized and several samples were cultured, including
the incision site, the subcutaneous tissue, the plate, bone,
and the biofilm membrane. Radiographic and histological
analyses were also performed from these samples. All sheep
in the group inoculated with the biofilm membrane showed
signs of infection, specifically osteomyelitis, at the 12-week
postoperative period in comparison with no infection in
any of the sheep treated without the biofilm. These findings
strongly support the hypothesis that biofilms can cause
infection. Although thismodel examines infection in an open
fracture model rather than an arthroplasty model, it provides
Figure 1: Photograph of a stainless steel plate and the PEEK mem-
brane used for preimplantation formation of biofilm used in the
Williams sheep model. Courtesy of Dr. D. Williams.
Figure 2: Intraoperative photographs of stainless steel plates placed
in the proximal tibia used in theWilliams et al. sheepmodel.Courte-
sy of Dr. D. Williams.
a key modification in animal modeling of arthroplasty with
this concept of biofilm inoculation as the inciting event [33].
Such studies using histology and culture data provide
extremely useful preclinical information; however, these
studies are costly and labor intensive and require the use of
a significant number of animals, as euthanasia is required to
determine the bacterial burden at each time point postopera-
tively. In 2010, Bernthal et al. published a novel mouse model
for post-arthroplasty infection that abdicated this need,
using in vivo imaging of bioluminescent bacteria to replace
histologic assessment [3]. Following a medial parapatellar
approach to the knee, ametal pin was placed retrograde, from
the knee joint into the femoral canal with 1mm of the pin
remaining protruding into the joint space. A bioluminescent
strain of bacteria was then used to inoculate the intra-
articular portion of themetal pin in the joint space (Figure 3).
Postoperatively, theXenogen in vivo imaging systemwas used
to monitor the infection by quantifying bacterial burden in
real-time (Figure 4). The in vivo bioluminescent signals were
confirmed to accurately represent the bacterial burden in vivo
by performing traditional bacterial counts on the last day of
imaging. The initial model was created with use of a stainless
steel Kirschner wire and a bioluminescent strain of S. aureus.
This model was then applied to test a variety of biomaterials
and various bacterial strains.Thismodel has unique elements
that may complement or provide an alternative to the use of
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(d) (e) (f)
(g) (h)
Figure 3: ((a)–(g)) Bernthal et al. surgical approach in a representative mouse. (h) A radiograph demonstrating placement of the implant in
the femoral canal with the cut end extending into the knee joint [3].
other previous animal models. One unique characteristic of
this model is that it uses advanced techniques of in vivo imag-
ing, which provides longitudinal, real-time quantification of
bacterial burden. Thus, an infection in a certain animal can
be followed over several days or even weeks (may simulate an
acute, subacute, or chronic post-arthroplasty infection). This
bypasses the need to euthanize a large number of animals at
subsequent time points to quantify bacterial burden. Genet-
ically modified mouse lines are readily available, which can
also be helpful in studying post-arthopalsty infections. For
example, the use of various immunologic knockout mice or
micewith fluorescent immune cellsmay aid in understanding
the complex immune response against such infections [34].
3. Conclusions
Researchers have come a long way since the initial animal
model of arthroplasty infection in 1975. The development
of novel scientific techniques, from biofilm harvesting to in
vivo imaging has provided opportunities to improve animal
models to a more accurate and humane depiction of the
human condition. And yet, each iteration along the way has
made an important contribution. The ideal model offers the
anatomic similarities to human joints that a large animal
model offers, the immunogenic modulation available in a
mouse model, the longitudinal data collection that biolumi-
nescence offers, and potentially, the use of biofilm inoculation
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Figure 4: Representative in vivo bioluminescent images [3].
that was recently described [31]. While all of these assets
may not be available in a single model, one could devise a
combination of existing models that utilizes the strengths of
small animal modeling as an initial high-throughput screen
and large animal modeling as a preclinical test. Additionally,
future models would ideally be able to test a representative
panel of bacteria, more accurately representing the clinical
scenarios that patients and clinicians face.
As the prevalence of periprosthetic infection continues to
rise alongside the increasing demand for arthroplasty, there
is a great need to identify both preventative and therapeutic
options. Such treatment strategies will continue to depend on
animal models as an intermediary between bench concepts
and clinical care. Thus, developing an appropriate, efficient
and accurate animal model or series thereof is of the utmost
importance.
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